Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-05

FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Propofol filed by Sagent Pharmaceuticals (ANDA075102).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)

Snippet

SUPPL AP for PROPOFOL (PROPOFOL)